Current developments in intraspinal agents for cancer and noncancer pain.
Since the late 1980s, intrathecal (IT) analgesic therapy has improved, and implantable IT drug delivery devices have become increasingly sophisticated. Physicians and patients now have myriad more options for agents and their combination, as well as for refining their delivery. As recently as 2007, The Polyanalgesic Consensus Conference of expert panelists updated its algorithm for drug selection in IT polyanalgesia. We review this algorithm and the emerging therapy included. This article provides an update on newly approved as well as emerging IT agents and the advances in technology for their delivery.
Lawson
Erin F
EF
Division of Pain Medicine, Department of Anesthesiology, University of California, San Diego, La Jolla, CA 92037, USA. erlawson@ucsd.edu
Wallace
Mark S
MS
D000465:Algorithms; D000700:Analgesics / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D007278:Injections, Spinal; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology
D000700:Analgesics